Skip to main content
. 2021 May 13;51(7):626–638. doi: 10.4070/kcj.2020.0527

Table 3. Stroke burden after adjustments.

Variables LAAO (n=30) NOAC (n=86) p value
Before adjustment
mRS before the event 0.3±0.2 0.6±0.1 0.22
mRS at discharge 1.8±0.3 2.7±0.2 0.03
mRS at 3 months 1.1±0.4 2.6±0.2 <0.01
mRS at 12 months 1.0±0.4 2.5±0.2 <0.01
After adjustment
Model 1*
mRS at discharge 1.8±0.3 2.7±0.2 0.03
mRS at 3 months 1.1±0.4 2.6±0.2 <0.01
mRS at 12 months 1.0±0.4 2.5±0.2 <0.01
Model 2*
mRS at discharge 1.8±0.3 2.7±0.2 0.03
mRS at 3 months 1.1±0.4 2.6±0.2 <0.01
mRS at 12 months 1.1±0.4 2.5±0.2 <0.01
Model 3*
mRS at discharge 1.9±0.3 2.6±0.2 0.07
mRS at 3 months 1.2±0.4 2.5±0.2 <0.01
mRS at 12 months 1.1±0.4 2.5±0.2 <0.01

Data are presented as the least square mean±standard error.

LAAO = left atrial appendage occlusion; mRS = modified Rankin Scale; NOAC = non-vitamin K antagonist oral anticoagulant.

*Model 1: adjusted for CHA2DS2-VASc score. Model 2: similar to model 1, with the additional inclusion of HAS-BLED score. Model 3: similar to model 2, with the additional inclusion of age, gender, and cardiovascular risk factors (age, sex, hypertension, diabetes mellitus, congestive heart failure and previous stroke/transient ischemic attack).